Revium Recovery, Inc. (RVRC)
1.43
-0.24
(-14.37%)
USD |
OTCM |
Aug 21, 16:00
Revium Recovery EPS Diluted (Quarterly) : -0.0096 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2025 | -0.0096 |
| June 30, 2025 | -0.0171 |
| March 31, 2025 | -0.0104 |
| December 31, 2024 | 0.0218 |
| September 30, 2024 | -0.0136 |
| June 30, 2024 | -5.235 |
| March 31, 2024 | -4.531 |
| December 31, 2023 | -0.732 |
| September 30, 2023 | -0.0057 |
| June 30, 2023 | -0.0066 |
| March 31, 2023 | -0.0077 |
| December 31, 2022 | -0.0081 |
| September 30, 2022 | -0.0094 |
| June 30, 2022 | -0.0103 |
| March 31, 2022 | -0.0152 |
| December 31, 2021 | -0.017 |
| September 30, 2021 | -0.0788 |
| June 30, 2021 | -0.0339 |
| March 31, 2021 | -0.0523 |
| December 31, 2020 | -0.0946 |
| Date | Value |
|---|---|
| September 30, 2020 | -0.645 |
| June 30, 2020 | -0.085 |
| March 31, 2020 | -0.745 |
| December 31, 2019 | -0.02 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | -0.065 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2010 | 4.17 |
| September 30, 2010 | -2.625 |
| June 30, 2010 | -1.04 |
| March 31, 2010 | -0.065 |
| December 31, 2009 | -0.125 |
| September 30, 2009 | -0.075 |
| June 30, 2009 | -0.955 |
| March 31, 2009 | -0.69 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| BioLineRx Ltd. | -0.5804 |
| XTL Biopharmaceuticals Ltd. | -- |
| Kamada Ltd. | 0.1605 |
| Can-Fite BioPharma Ltd. | -- |
| Galmed Pharmaceuticals Ltd. | -2.318 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.584M |
| Total Expenses (Quarterly) | 0.584M |